Companies with a Future performance score of at least 3, ordered by Future performance score.
Pharmaceuticals & Biotech
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications.
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of hospital-focused pharmaceuticals to treat unmet medical needs.
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
Oncimmune Holdings Plc, an early cancer detection company, develops and commercializes products to diagnose cancer in the United Kingdom and North America.
Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People’s Republic of China and Hong Kong.
Optibiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom.
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide.
Silence Therapeutics plc focuses on the discovery, development, and delivery of novel RNA therapeutics in haematology, cardiovascular, and other rare and metabolic indications.
Horizon Discovery Group plc, a translational genomics company, develops and supplies patient-relevant drug discovery and diagnostic reference standards in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.
IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide.
As of June 28, 2019, Venn Life Sciences Holdings Plc was acquired by Open Orphan Designated Activity Company, in a reverse merger transaction.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia.
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide.
Diaceutics Plc provides data analytics and implementation services for pharmaceutical companies worldwide.
Ergomed plc provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom and Rest of Europe, the Middle East, Africa, North America, Asia, and Australia.
Clinigen Group plc operates as a specialty pharmaceutical and services company.